Skip to main content
TipRanks
Go Ultimate75% OFF

Nascent Pharma Holdings (NASC) Ratios

28 Followers

Nascent Pharma Holdings Ratios

NASC's free cash flow for Q3 2024 was $9.10K. For the 2024 fiscal year, NASC's free cash flow was increased by $0.00 and operating cash flow was $9.10K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 24Dec 23Dec 22Dec 21Mar 21
Liquidity Ratios
Current Ratio0.020.480.700.701.27
Quick Ratio0.020.340.540.431.11
Cash Ratio0.000.000.010.050.21
Solvency Ratio-0.76-0.75-1.05-1.07-3.32
Operating Cash Flow Ratio-0.02-0.12-0.32-0.77-0.88
Short-Term Operating Cash Flow Coverage-0.03-0.15-0.48-1.44-1.07
Net Current Asset Value$ -12.74M$ -5.75M$ -4.16M$ -4.20M$ 381.26K
Leverage Ratios
Debt-to-Assets Ratio27.720.910.600.440.53
Debt-to-Equity Ratio-0.65-9.163.461.301.41
Debt-to-Capital Ratio-1.881.120.780.560.59
Long-Term Debt-to-Capital Ratio0.000.000.140.200.12
Financial Leverage Ratio-0.02-10.115.772.932.65
Debt Service Coverage Ratio-0.76-0.51-1.38-1.33-2.59
Interest Coverage Ratio-2.68-2.98-15.71-4.88-8.06
Debt to Market Cap3.9926.761.879.6413.20
Interest Debt Per Share0.170.932.876.9912.80
Net Debt to EBITDA-1.08-1.57-0.74-0.72-0.23
Profitability Margins
Gross Profit Margin0.00%16.64%39.11%64.99%83.74%
EBIT Margin0.00%-334.78%-209.73%-218.65%-464.47%
EBITDA Margin0.00%-269.84%-188.26%-206.87%-418.66%
Operating Profit Margin0.00%-347.28%-211.92%-222.99%-440.83%
Pretax Profit Margin0.00%-451.25%-223.22%-264.31%-519.14%
Net Profit Margin0.00%-451.70%-223.23%-264.33%-519.33%
Continuous Operations Profit Margin0.00%-451.70%-223.23%-264.33%-519.33%
Net Income Per EBT104.37%100.10%100.01%100.01%100.04%
EBT Per EBIT205.45%129.94%105.33%118.53%117.76%
Return on Assets (ROA)-3406.45%-96.16%-95.92%-73.87%-226.99%
Return on Equity (ROE)80.19%971.83%-553.17%-216.56%-601.54%
Return on Capital Employed (ROCE)37.40%747.17%-451.79%-146.41%-446.90%
Return on Invested Capital (ROIC)107.66%-91.53%-117.73%-79.56%-211.86%
Return on Tangible Assets-3406.45%-97.07%-96.58%-75.56%-266.41%
Earnings Yield-490.35%-2918.56%-321.56%-1811.98%-5796.74%
Efficiency Ratios
Receivables Turnover0.000.581.021.260.85
Payables Turnover0.190.921.301.391.81
Inventory Turnover0.001.112.010.630.81
Fixed Asset Turnover0.000.491.020.501.62
Asset Turnover0.000.210.430.280.44
Working Capital Turnover Ratio0.00-0.46-2.05-4.150.98
Cash Conversion Cycle-1964.00564.26259.49603.94679.39
Days of Sales Outstanding0.00630.42359.58289.12428.26
Days of Inventory Outstanding0.00328.95181.47578.26452.81
Days of Payables Outstanding1964.00395.10281.55263.44201.68
Operating Cycle0.00959.37541.05867.38881.06
Cash Flow Ratios
Operating Cash Flow Per Share-0.00-0.10-1.11-5.45-8.26
Free Cash Flow Per Share-0.00-0.10-1.11-5.98-8.48
Dividend Paid and CapEx Coverage Ratio0.00-86.970.00-10.22-38.77
Capital Expenditure Coverage Ratio0.00-86.970.00-10.22-38.77
Operating Cash Flow Coverage Ratio-0.03-0.14-0.42-1.01-0.94
Operating Cash Flow to Sales Ratio0.00-0.61-0.59-1.59-1.14
Free Cash Flow Yield-10.65%-395.49%-85.05%-1196.99%-1303.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.21-0.03-0.31-0.06-0.02
Price-to-Sales (P/S) Ratio0.000.150.690.150.09
Price-to-Book (P/B) Ratio-0.16-0.331.720.120.10
Price-to-Free Cash Flow (P/FCF) Ratio-9.39-0.25-1.18-0.08-0.08
Price-to-Operating Cash Flow Ratio-9.39-0.26-1.18-0.09-0.08
Price-to-Earnings Growth (PEG) Ratio0.000.000.010.000.00
Enterprise Value Multiple-1.36-1.63-1.10-0.79-0.25
Enterprise Value10.38M9.48M13.90M7.51M1.78M
EV to EBITDA-1.36-1.63-1.10-0.79-0.25
EV to Sales0.004.402.081.631.04
EV to Free Cash Flow-46.83-7.19-3.52-0.93-0.89
EV to Operating Cash Flow-46.83-7.27-3.52-1.03-0.91
Tangible Book Value Per Share-0.22-0.090.733.913.81
Shareholders’ Equity Per Share-0.22-0.080.764.186.26
Tax and Other Ratios
Effective Tax Rate0.00-0.00-0.00-0.00-0.00
Revenue Per Share0.000.171.873.437.26
Net Income Per Share-0.17-0.77-4.18-9.06-37.68
Tax Burden1.041.001.001.001.00
Interest Burden1.221.351.061.211.12
Research & Development to Revenue0.000.000.000.000.10
SG&A to Revenue0.002.202.032.092.70
Stock-Based Compensation to Revenue0.000.670.760.521.51
Income Quality0.020.130.260.600.34

Currency in USD